Axsome TherapeuticsAXSM
那斯達克 · USD
103.02
+1.64
(+1.62%)
收盤 08/02 03:59 (UTC+8)
盤後
0
0
(0%)
08/02 03:59 (UTC+8)
Axsome TherapeuticsAXSM
103.02
+1.64
(+1.62%)
財務數據
損益表
- 0.24
- 0.95
- 0.47
- 0.58
- 0.72
- 0.75
- 0.87
- 1.05
- 1.19
- 1.21
- 44.67
- 288.05
- -50.62
- 23.76
- 23.77
- 4.85
- 16.22
- 20.19
- 13.37
- 2.27
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | 2023/Q2 | 2023/Q1 | 2022/Q4 | |
營業收入淨額 | 121,463 | 118,766 | 104,762 | 87,166 | 74,999 | 71,530 | 57,794 | 46,700 | 94,576 | 24,371 |
營業成本 | 9,789 | 10,514 | 8,437 | 8,055 | 6,297 | 7,378 | 6,532 | 4,599 | 7,556 | 2,291 |
營業毛利 | 111,674 | 108,252 | 96,325 | 79,111 | 68,702 | 64,152 | 51,262 | 42,101 | 87,020 | 22,081 |
營業費用 | - | - | - | - | - | 162,426 | 113,382 | 107,158 | 93,394 | 81,998 |
研發費用 | 44,785 | 55,006 | 45,388 | 49,853 | 36,830 | 30,803 | 28,767 | 20,581 | 17,793 | 14,693 |
推銷及管理費用 | 122,299 | 124,256 | 111,955 | 105,714 | 97,558 | 130,016 | 83,008 | 84,988 | 74,029 | 65,698 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | 1,572 | 1,607 | 1,606 | 1,590 | 1,589 | 1,607 | 1,607 | 1,589 | 1,572 | 1,607 |
營業利益 | -56,982 | -72,617 | -62,624 | -78,046 | -67,275 | -98,274 | -62,120 | -65,057 | -6,374 | -59,918 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 2,431 | 2,210 | 1,978 | 1,299 | 1,082 | 702 | 757 | 2,730 | 2,264 | 1,323 |
稅前純益 | -59,413 | -74,827 | -64,602 | -79,345 | -68,357 | -98,976 | -62,877 | -67,787 | -8,638 | -61,241 |
所得稅 | - | 85 | - | - | - | -325 | -678 | -617 | 2,580 | - |
稅後純益 | -59,413 | -74,912 | -64,602 | -79,345 | -68,357 | -98,651 | -62,199 | -67,170 | -11,218 | -61,241 |
基本每股稅後盈餘(元) | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 |
稀釋每股稅後盈餘(元) | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.13 | -1.34 | -1.54 | -0.26 | -1.43 |
基本平均股數(千股) | 48871.00 | 48541.00 | 48140.00 | 47573.00 | 47393.00 | 47329.00 | 47117.00 | 43669.00 | 43523.00 | 43447.00 |
稀釋平均股數(千股) | 48871.00 | 48541.00 | 48140.00 | 47573.00 | 47393.00 | 47329.00 | 47117.00 | 43669.00 | 43523.00 | 43447.00 |
還原基本每股稅後盈餘(元) | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.08 | -1.32 | -1.54 | -0.26 | -1.41 |
還原稀釋每股稅後盈餘(元) | -1.22 | -1.54 | -1.34 | -1.67 | -1.44 | -2.13 | -1.34 | -1.54 | -0.26 | -1.43 |
還原基本平均股數(千股) | 48,871 | 48,541 | 48,140 | 47,573 | 47,393 | 47,329 | 47,117 | 43,669 | 43,523 | 43,447 |
還原稀釋平均股數(千股) | 48,871 | 48,541 | 48,140 | 47,573 | 47,393 | 47,329 | 47,117 | 43,669 | 43,523 | 43,447 |
EBITDA(千元) | -54,182 | -69,836 | -59,891 | -75,412 | -64,825 | -96,080 | -59,750 | -62,459 | -3,814 | -56,718 |